Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$417M |
| 2 |
Marriott International
MAR
|
+$194M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$143M |
| 4 |
Enbridge
ENB
|
+$129M |
| 5 |
Oracle
ORCL
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$140M |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
+$126M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$125M |
| 4 |
Amgen
AMGN
|
+$86.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22% |
| 2 | Industrials | 9.19% |
| 3 | Energy | 8.99% |
| 4 | Communication Services | 7.21% |
| 5 | Technology | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6276
LCNB Corp
LCNB
$283M
| $1K | ﹤0.01% |
72
-304
| -81% | -$6.42K |
|
6277
Liquidity Services
LQDT
$1.34B
| $1K | ﹤0.01% |
200
-701
| -78% | -$4.88K |
|
6278
Lisata Therapeutics
LSTA
$10.3M
| $1K | ﹤0.01% |
20
+12
| +150% | +$848 |
|
6279
Medifast
MED
$131M
| $1K | ﹤0.01% |
22
-45
| -67% | -$1.96K |
|
6280
MediciNova
MNOV
$65M
| $1K | ﹤0.01% |
162
-714
| -82% | -$4K |
|
6281
Microvision
MVIS
$92.1M
| $1K | ﹤0.01% |
27
+5
| +23% | +$161 |
|
6282
National Bank Holdings
NBHC
$1.93B
| $1K | ﹤0.01% |
18
-417
| -96% | -$13.3K |
|
6283
NCS Multistage Holdings
NCSM
$131M
| $1K | ﹤0.01% |
+1
| New | +$470 |
|
6284
Minerva Neurosciences
NERV
$186M
| $1K | ﹤0.01% |
15
-83
| -85% | -$5.37K |
|
6285
NMI Holdings
NMIH
$3.39B
| $1K | ﹤0.01% |
89
-2,043
| -96% | -$23K |
|
6286
NanoViricides
NNVC
$34.4M
| $1K | ﹤0.01% |
35
| – | – |
|
6287
NI Holdings
NODK
$315M
| $1K | ﹤0.01% |
+43
| New | +$718 |
|
6288
Okta
OKTA
$26.1B
| $1K | ﹤0.01% |
+28
| New | +$692 |
|
6289
Old Second Bancorp
OSBC
$1.32B
| $1K | ﹤0.01% |
104
-939
| -90% | -$10.9K |
|
6290
PDF Solutions
PDFS
$2.18B
| $1K | ﹤0.01% |
65
-841
| -93% | -$15.6K |
|
6291
Penumbra
PEN
$12.9B
| $1K | ﹤0.01% |
7
-869
| -99% | -$73.8K |
|
6292
Preformed Line Products
PLPC
$2.29B
| $1K | ﹤0.01% |
17
-203
| -92% | -$10K |
|
6293
Protagonist Therapeutics
PTGX
$9.97B
| $1K | ﹤0.01% |
52
-191
| -79% | -$2.04K |
|
6294
QuidelOrtho
QDEL
$1.01B
| $1K | ﹤0.01% |
31
-937
| -97% | -$23.2K |
|
6295
Rigel Pharmaceuticals
RIGL
$761M
| $1K | ﹤0.01% |
34
-451
| -93% | -$12.3K |
|
6296
Rush Enterprises Class B
RUSHB
$9.24B
| $1K | ﹤0.01% |
77
-508
| -87% | -$7.59K |
|
6297
Silvercrest Asset Management
SAMG
$79.3M
| $1K | ﹤0.01% |
73
-201
| -73% | -$2.62K |
|
6298
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $1K | ﹤0.01% |
39
-743
| -95% | -$17.7K |
|
|
SHOE
6299
Shoe Station Group
SHOE
$421M
| $1K | ﹤0.01% |
86
-518
| -86% | -$5.71K |
|
6300
Syndax Pharmaceuticals
SNDX
$1.74B
| $1K | ﹤0.01% |
36
-200
| -85% | -$2.29K |
|
Similar funds
Royal Bank of Canada's Q2 2017 Portfolio in Review
As of Q2 2017, Royal Bank of Canada held 7,189 positions worth $194B, up 4.3% from $186B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q2 2017 filing shows 430 new, 2,465 increased, 3,124 reduced and 398 closed positions. Its largest new stake was Altaba Inc: 305,426 shares worth $16.6M. The largest sale was iShares Russell 2000 ETF, an estimated $140M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Energy.
- Royal Bank of Canada's largest Q2 2017 buy was Altaba Inc: 305,426 shares worth $16.6M.
- Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $417M increase.
- Royal Bank of Canada's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $140M.
- Royal Bank of Canada fully exited Brookfield Can Office Properties in Q2 2017, selling an estimated $49.5M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $194B portfolio in Q2 2017.
- Royal Bank of Canada opened 430 new positions and closed 398 in Q2 2017.
- Royal Bank of Canada's portfolio value rose 4.3% quarter-over-quarter to $194B.
Based on Royal Bank of Canada's 13F filing for Q2 2017, filed 14 Aug 2017.